Oncology Data Advisor
Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:05:36
- More information
Informações:
Synopsis
The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do I tell them?
